Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock

112.9 EUR
-0.8 (-0.7%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

6

Overall BIM gets a fundamental rating of 6 out of 10. We evaluated BIM against 65 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BIM was profitable.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
BIM had a positive operating cash flow in each of the past 5 years.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.04%, BIM is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
BIM has a Return On Equity of 9.61%. This is in the better half of the industry: BIM outperforms 61.54% of its industry peers.
BIM's Return On Invested Capital of 8.55% is fine compared to the rest of the industry. BIM outperforms 70.77% of its industry peers.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 10.04%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.55%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 9.17%, BIM is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
BIM's Profit Margin has been stable in the last couple of years.
BIM has a Operating Margin (12.37%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BIM has grown nicely.
Looking at the Gross Margin, with a value of 56.27%, BIM is in line with its industry, outperforming 50.77% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.85%
OM growth 5Y2.1%
PM growth 3Y-15.21%
PM growth 5Y1.25%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

BIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BIM has about the same amout of shares outstanding than it did 1 year ago.
BIM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BIM has been reduced compared to a year ago.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 7.04 indicates that BIM is not in any danger for bankruptcy at the moment.
BIM has a Altman-Z score of 7.04. This is amongst the best in the industry. BIM outperforms 92.31% of its industry peers.
BIM has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.15, BIM belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that BIM is not too dependend on debt financing.
The Debt to Equity ratio of BIM (0.09) is better than 78.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 7.04
ROIC/WACC1.08
WACC7.92%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.27 indicates that BIM has no problem at all paying its short term obligations.
BIM has a better Current ratio (2.27) than 66.15% of its industry peers.
BIM has a Quick Ratio of 1.30. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.30, BIM is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The earnings per share for BIM have decreased by -8.57% in the last year.
Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
The Revenue has grown by 8.28% in the past year. This is quite good.
BIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.27% yearly.
EPS 1Y (TTM)-8.57%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.12% yearly.
BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y12.12%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y6.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.25, the valuation of BIM can be described as expensive.
63.08% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.19, BIM is valued at the same level.
With a Price/Forward Earnings ratio of 22.29, BIM is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BIM is on the same level as its industry peers.
BIM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.25
Fwd PE 22.29
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 69.23% of the companies listed in the same industry.
66.15% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 30.44
EV/EBITDA 13.77
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 13.42% in the coming years.
PEG (NY)1.78
PEG (5Y)2.68
EPS Next 2Y14.56%
EPS Next 3Y13.42%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.82%, BIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.98, BIM pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.82, BIM pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

The dividend of BIM is nicely growing with an annual growth rate of 19.36%!
Dividend Growth(5Y)19.36%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

28.04% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.04%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (1/9/2026, 7:00:00 PM)

112.9

-0.8 (-0.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04
Earnings (Next)03-05 2026-03-05/amc
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap13.36B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts74.12
Price Target128.35 (13.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.85
Dividend Growth(5Y)19.36%
DP28.04%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.62%
PT rev (3m)0.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 29.25
Fwd PE 22.29
P/S 3.24
P/FCF 30.44
P/OCF 16.96
P/B 3.4
P/tB 4.78
EV/EBITDA 13.77
EPS(TTM)3.86
EY3.42%
EPS(NY)5.07
Fwd EY4.49%
FCF(TTM)3.71
FCFY3.29%
OCF(TTM)6.66
OCFY5.9%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.78
PEG (5Y)2.68
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.69%
ROIC 8.55%
ROICexc 9.37%
ROICexgc 13.09%
OM 12.37%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.11%
ROCE(3y)13.72%
ROCE(5y)16.21%
ROICexgc growth 3Y-22.61%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.09%
ROICexc growth 5Y-1.65%
OM growth 3Y-12.85%
OM growth 5Y2.1%
PM growth 3Y-15.21%
PM growth 5Y1.25%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.47%
Cap/Sales 8.47%
Interest Coverage 250
Cash Conversion 80%
Profit Quality 116.14%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 7.04
F-Score8
WACC7.92%
ROIC/WACC1.08
Cap/Depr(3y)244.4%
Cap/Depr(5y)271.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.61%
Profit Quality(5y)62.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.57%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y16.45%
EPS Next 2Y14.56%
EPS Next 3Y13.42%
EPS Next 5Y12.12%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y6.02%
EBIT growth 1Y-1.77%
EBIT growth 3Y-7.94%
EBIT growth 5Y10.55%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y18.21%
FCF growth 1Y133.64%
FCF growth 3Y-15.64%
FCF growth 5Y18.84%
OCF growth 1Y66.91%
OCF growth 3Y-6.83%
OCF growth 5Y10.34%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 4 / 10 and the dividend payout ratio is 28.04%.